• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrob Agents Chemother. Tripoli metallo-β-lactamase-1 (TMB-1)-producing Acinetobacter spp. with decreased resistance to imipenem in Japan

Giuseppe

Emeritus
[Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]


Tripoli metallo-β-lactamase-1 (TMB-1)-producing Acinetobacter spp. with decreased resistance to imipenem in Japan

Shizuo Kayama 1,2, Norifumi Shigemoto 1,2,3, Wataru Shimizu 1,2,3, Ryuichi Kuwahara 1,2,4, Mitsuyasu Ikeda 1,2,5, Kouji Ikebe 1,5, Kikuyo Maeda 2, Junzo Hisatsune 1,2, Hiroki Ohge 1,6 and Motoyuki Sugai 1,2

Published ahead of print 21 January 2014, doi: 10.1128/AAC.01790-13 <CITE>AAC.01790-13 </CITE>
<CITE></CITE>
Author Affiliations: <SUP>1</SUP>Project Research Center for Nosocomial Infectious Diseases, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima 734-8551 <SUP>2</SUP>Department of Bacteriology, Hiroshima University Graduate School of Biomedical & Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima 734-8551 <SUP>3</SUP>Department of Surgery I, Hiroshima University Graduate School of Biomedical & Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima 734-8551 <SUP>4</SUP>Clinical laboratory, Hiroshima General Hospital of West Japan Railway Company, Futaba-no-sato 3-1-36, Higashi-ku, Hiroshima, Hiroshima 732-0057, Japan <SUP>5</SUP>Clinical laboratory, JA Hiroshima General Hospital, Hatsukaichi, Hiroshima 738-8503, Japan <SUP>6</SUP>Department of Infectious Diseases, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima 734-8551


ABSTRACT

We recently reported Klebsiella pneumoniae carrying bla<SUB>IMP</SUB>-type metallo-β-lactamase gene variants showing paradoxical resistant phenotype: resistant to virtually all β-lactams except imipenem (1, 2).?


FOOTNOTES

Corresponding to: Motoyuki Sugai, Department of Bacteriology, Hiroshima University Graduate School of Biomedical & Health Sciences, Kasumi 1-2-3 Hiroshima, Hiroshima 734-8551. Phone (81) 082 257 5635, Fax (81) 082 257 5639, E-mail: sugai@hiroshima-u.ac.jp

Copyright ? 2014, American Society for Microbiology. All Rights Reserved.


-
------
 
Back
Top Bottom